相关实验视频

Updated: Jul 12, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

在质母细胞瘤中应对免疫挑战:探索克服免疫抑制的免疫治疗途径

Prateek Jain¹, Shambhavi Vashist², Binay K Panjiyar^3,4

¹Internal Medicine, Maulana Azad Medical College, Delhi, IND.

|October 30, 2023

概括

免疫疗法对多形质母细胞瘤 (GBM) 脑瘤有希望,但面临着重大挑战. 进一步的研究和个性化治疗组合对于改善患者的治疗结果至关重要.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

多形质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性原发性脑瘤.
目前的治疗方法 (手术,辐射,temozolomide) 提供了有限的生存益处.
在GBM管理中的挑战包括血脑屏障,免疫抑制瘤微环境和手术复杂性.

研究的目的:

审查目前针对多形质母细胞瘤的免疫疗法的现状.
评估各种免疫治疗策略在GBM治疗中的潜力和局限性.
确定未来的研究方向,以改善GBM患者的治疗结果.

主要方法:

对过去十年26项高质量的研究进行了全面的文献综述.
在主要的科学数据库 (PubMed,Google Scholar) 中进行的搜索.
分析的重点是免疫治疗策略,包括检查点抑制剂,疫苗,CAR T细胞疗法和瘤病毒.

主要成果:

免疫疗法在其他癌症 (例如,非小细胞肺癌,血液恶性瘤) 中也取得了成功.
一些免疫治疗方法正在针对GBM进行研究.
尽管临床前数据充满希望,但显著的局限性和挑战阻碍了GBM免疫治疗的实际应用.

结论:

免疫疗法代表了质母细胞瘤多形瘤的潜在新型治疗途径.
目前的免疫治疗策略在治疗GBM的临床有效性方面面临重大障碍.
未来的方向强调组合疗法,个性化治疗方法和持续的研究,以提高GBM治疗的有效性.

关键词:

汽车T细胞治疗质母细胞瘤治疗疗法第四级质母细胞瘤免疫检查点抑制剂免疫检查点抑制剂免疫疗法免疫疗法型病毒型病毒复发性多形质母细胞瘤治疗癌症疫苗的治疗方法

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...